Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes by Kodosaki, Eleftheria, Watkins, W John, Loveless, Sam, Kreft, Karim L, Richards, Aidan, Anderson, Valerie, Hurler, Lisa, Robertson, Neil P, Zelek, Wioleta M, Tallantyre, Emma C

Get full text

Complement activation in multiple sclerosis plaques: an immunohistochemical analysis by Ingram, Gillian, Loveless, Sam, Howell, Owain W, Hakobyan, Svetlana, Dancey, Bethan, Harris, Claire L, Robertson, Neil P, Neal, James W, Morgan, B Paul

Get full text

CCN3 is dynamically regulated by treatment and disease state in multiple sclerosis by Naughton, Michelle, Moffat, Jill, Eleftheriadis, George, de la Vega Gallardo, Nira, Young, Andrew, Falconer, John, Hawkins, Kristen, Pearson, Ben, Perbal, Bernard, Hogan, Andrew, Moynagh, Paul, Loveless, Sam, Robertson, Neil P, Gran, Bruno, Kee, Rachael, Hughes, Stella, McDonnell, Gavin, Howell, Owain, Fitzgerald, Denise C

Get full text

Complement regulator factor H as a serum biomarker of multiple sclerosis disease state by Ingram, Gillian, Hakobyan, Svetlana, Hirst, Claire L., Harris, Claire L., Pickersgill, Trevor P., Cossburn, Mark D., Loveless, Sam, Robertson, Neil P., Morgan, Bryan Paul

Get full text

Fault architecture and deformation processes within poorly lithified rift sediments, Central Greece by Loveless, Sian, Bense, Victor, Turner, Jenni

Get full text

Relevance of Multiple Sclerosis Severity Genotype in Predicting Disease Course: A Real‐World Cohort by Kreft, Karim L., Uzochukwu, Emeka, Loveless, Sam, Willis, Mark, Wynford‐Thomas, Ray, Harding, Katharine E., Holmans, Peter, Lawton, Michael, Tallantyre, Emma C., Robertson, Neil P.

Get full text

Complement is activated in progressive multiple sclerosis cortical grey matter lesions by Watkins, Lewis M, Neal, James W, Loveless, Sam, Michailidou, Iliana, Ramaglia, Valeria, Rees, Mark I, Reynolds, Richard, Robertson, Neil P, Morgan, B Paul, Howell, Owain W

Get full text

Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis by Loveless, Sam, Neal, James W., Howell, Owain W., Harding, Katharine E., Sarkies, Patrick, Evans, Rhian, Bevan, Ryan J., Hakobyan, Svetlana, Harris, Claire L., Robertson, Neil P., Morgan, Bryan Paul

Get full text

Serum neurofilament-light concentration and real-world outcome in MS by Anderson, Valerie, Bentley, Emily, Loveless, Sam, Bianchi, Lucia, Harding, Katharine E., Wynford-Thomas, Ray A., Joseph, Fady, Giovannoni, Gavin, Gnanapavan, Sharmilee, Robertson, Neil P., Marta, Monica, Tallantyre, Emma C.

Get full text

High levels of soluble CD59 in CSF compared to plasma suggests intrathecal source of soluble CD59 by Zelek, Wioleta, Willems, Loek, Brandwijk, Ricardo, Loveless, Sam, Robertson, Neil R., Morgan, B. Paul

Get full text

Subcutaneous administration of natalizumab can lead to lower drug concentrations compared to intravenous administration by Gelissen, Liza M.Y., Loveless, Sam, Toorop, Alyssa A., Howlett, Jayne, Loeff, Floris C., Rispens, Theo, Killestein, Joep, Tallantyre, Emma C., van Kempen, Zoé L.E.

Get full text

Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59 by Zelek, Wioleta M, Watkins, Lewis M, Howell, Owain W, Evans, Rhian, Loveless, Sam, Robertson, Neil P, Beenes, Marijke, Willems, Loek, Brandwijk, Ricardo, Morgan, B Paul

Get full text

Complement system biomarkers in demyelinating disease by Zelek, Wioleta, Fathalla, Dina, Orme, Rowan P, Morgan, Angharad, Touchard, Samuel, O’Hagan, Caroline, Loveless, Sam, Robertson, Neil, Morgan, B. Paul

Get full text

Music to slam doors to by Wolfson, Sam, Loveless, Rory, Loveless, Eoin

Get full text